Bijal Shah, MD, Moffitt Cancer Center
Advertisement
Articles by Bijal Shah, MD, Moffitt Cancer Center
Advertisement
Latest Updated Articles
An Introduction to Mantle Cell Lymphoma & KTE-X19Published: June 24th 2020 | Updated:
Future Directions in Mantle Cell LymphomaPublished: June 24th 2020 | Updated:
A Look at ZUMA-2 TrialPublished: June 24th 2020 | Updated:
Bruton Tyrosine Kinase InhibitorsPublished: June 24th 2020 | Updated:
ASCO 2020: ZUMA-2 UpdatePublished: June 24th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
2
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
3
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
4
Orca-T With Reduced-Intensity Conditioning Yields Robust Efficacy in Hematologic Malignancies
5